Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-05-29T04:01:55.601Z Has data issue: false hasContentIssue false

8 - Cysteamine treatment of nephropathic cystinosis

from SECTION III - UTILIZATION OF ALTERNATIVE PATHWAYS

Published online by Cambridge University Press:  17 November 2010

By
Jess G. Thoene
Edited by
Jess G. Thoene
Jess G. Thoene
Affiliation:
University of Michigan, Ann Arbor
Get access
Type
Chapter
Information
Small Molecule Therapy for Genetic Disease , pp. 101 - 113
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gahl, WA, Thoene, J, Schneider, J. Cystinosis: A disorder of lysosomal membrane transport. Scriver, C., Beaudet, A., Sly, W., Valle, D., eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edition, McGraw Hill, 5085–5108, 2001Google Scholar
Palacin, M, Goodyear, P, Nunes, V, Gasparini, P. Cystinuria, C. Scriver, A. Beaudet, W. Sly, D. Valle, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edition, McGraw Hill, 4909–4932, 2001Google Scholar
Town, M, Cherqui, S, Attard, M, Forestier, L, Whitmore, SA, Callen, DF, Gribouval, O, Broyer, M, Bates, GP,van't Hoff, W, Antignac, C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet. 1998;18:319–324CrossRefGoogle ScholarPubMed
Gahl, WG, Thoene, JG, Schneider, JA. Cystinosis. N Engl J Med. 2002;347:111–121CrossRefGoogle ScholarPubMed
Thoene, J. A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab. 2007;92:292–298CrossRefGoogle ScholarPubMed
Park, M, Pejovic, V, Kerisit, K, Junius, S, Thoene, J. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of PKCδ. J Am Soc Nephrol. 2006;17:3167–3175CrossRefGoogle Scholar
Park, M, Nair, R, Walker, P, Thoene, J. The renal proximal tubule phenotype in cystinosis results from increased apoptosis. (Abstract) PAS. 2005;57:1096Google Scholar
Baum, M. The Fanconi syndrome of cystinosis: Insights into the pathophysiology. Pediatr Nephrol. 1998;12:492–497CrossRefGoogle ScholarPubMed
McDowell, GA, Gahl, WA, Stephenson, , Schneider, JA, Weissenbach, J, Polymeropoulos, MH, Town, MM, van't Hoff, W, Farrall, M, Mathews, CG. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet. 1995;10:246–248CrossRefGoogle Scholar
Shotelersuk, V, Larson, D, Anikster, Y, McDowell, G, Lemons, R, Bernardini, I, Guo, J, Thoene, J, Gahl, W. CTNS mutations in an American based population of cystinosis patients. Am J Hum Genet. 1998;63:1352–1362CrossRefGoogle Scholar
Thoene, J, Lemons, R, Anikster, Y, Mullet, J, Paelicke, K, Lucero, C, Gahl, W, Schneider, J, Shu, SG, Campbell, HT. Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab. 1999;67:283–293CrossRefGoogle ScholarPubMed
Anikster, Y, Lucero, C, Guo, J, Huizing, M, Shotelersuk, V, Bernardini, I, McDowell, G, Iwata, F, Kaiser-Kupfer, MI, Jaffe, R, Thoene, J, Schneider, JA, Gahl, WA. Ocular nonnephropathic cystinosis: Clinical, biochemical, and molecular correlations. Pediatr Res. 2000;47:17–23CrossRefGoogle ScholarPubMed
Giuseppe, B. Conformational analysis and rotation barriers of 2-aminoethanethiol and 2-aminoethanol: An ab initio study. Int J Quantum Chem. 1996;59:227–237Google Scholar
Thoene, J, Oshima, R, Crawhall, J, Olson, D, Schneider, J. Cystinosis: Intracellular cystine depletion by aminothiols in vitro and in vivo. J. Clin. Invest. 1976;58:180–189Google ScholarPubMed
Smolin, , Clark, KF, Thoene, JG, Gahl, WA, Schneider, JA. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res. 1988;23:616–620CrossRefGoogle ScholarPubMed
Gahl, WA, Tietze, F, Butler, JD, Schulman, JD. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J. 1985;22:545–550CrossRefGoogle Scholar
Pisoni, RL, Thoene, JG, Christensen, HN. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?J Biol Chem. 1985;260:4791–4798Google ScholarPubMed
Corden, BJ, Schulman, JD, Schneider, JA, Thoene, JG. Adverse reactions to oral cysteamine use in nephropathic cystinosis. Dev Pharmacol Ther. 1981;3:25–30CrossRefGoogle ScholarPubMed
Gahl, WA, Reed, GF, Thoene, JG, Schulman, JD, Rizzo, WB, Jonas, AJ, Denman, DW, Schlesselman, JJ, Corden, BJ, Schneider, JA. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987;316:971–977CrossRefGoogle ScholarPubMed
Nesterova, G, Gahl, W. Nephropathic cystinosis: Late complications of a multisystemic disease. Pediatr Nephrol. 2008;6:863–878CrossRefGoogle Scholar
http://www.drugs.com/pro/cystagon.html
Gahl, WA, Schneider, JA, Schulman, JD, Thoene, JG, Reed, GF. Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol. 1990;4:129–135CrossRefGoogle ScholarPubMed
Kimonis, VE, Troendle, J, Rose, SR, Yang, ML, Markello, TC, Gahl, WA. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab. 1995;80:3257–3261Google ScholarPubMed
Tsilou, ET, Thompson, D, Lindblad, AS, Reed, GF, Rubin, B, Gahl, W, Thoene, J, Del Monte, M, Schneider, JA, Granet, DB, Kaiser-Kupfer, MI. A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol. 2003;87:28–31CrossRefGoogle ScholarPubMed
Thoene, JG, Lemons, R. Cystine depletion of cystinotic tissues by phosphocysteamine (WR638). J Pediatr. 1980;96:1043–1044CrossRefGoogle Scholar
Wittwer, CT, Gahl, WA, Butler, JD, Zatz, M, Thoene, JG. Metabolism of pantethine in cystinosis. J Clin Invest. 1985;76:1665–1672CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×